These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11779086

  • 21. Celecoxib with chemotherapy in colorectal cancer.
    Blanke CD.
    Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):17-21. PubMed ID: 12014863
    [Abstract] [Full Text] [Related]

  • 22. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model.
    Khan AA, Brahim JS, Rowan JS, Dionne RA.
    Clin Pharmacol Ther; 2002 Jul; 72(1):44-9. PubMed ID: 12152003
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
    Waskewich C, Blumenthal RD, Li H, Stein R, Goldenberg DM, Burton J.
    Cancer Res; 2002 Apr 01; 62(7):2029-33. PubMed ID: 11929821
    [Abstract] [Full Text] [Related]

  • 25. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo.
    Johnsen JI, Lindskog M, Ponthan F, Pettersen I, Elfman L, Orrego A, Sveinbjörnsson B, Kogner P.
    Cancer Res; 2004 Oct 15; 64(20):7210-5. PubMed ID: 15492235
    [Abstract] [Full Text] [Related]

  • 28. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
    Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas MA, Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G.
    N Engl J Med; 2000 Jun 29; 342(26):1946-52. PubMed ID: 10874062
    [Abstract] [Full Text] [Related]

  • 29. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR, DuBois RN.
    J Clin Oncol; 2005 Apr 20; 23(12):2840-55. PubMed ID: 15837998
    [Abstract] [Full Text] [Related]

  • 30. [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part I. Clinical efficacy].
    Burdan F, Korobowicz A.
    Pol Merkur Lekarski; 2003 Apr 20; 14(82):348-51. PubMed ID: 12868200
    [Abstract] [Full Text] [Related]

  • 31. Increased expression of cyclooxygenase (COX)-2 in DMBA-induced hamster cheek pouch carcinogenesis and chemopreventive effect of a selective COX-2 inhibitor celecoxib.
    Nishimura N, Urade M, Hashitani S, Noguchi K, Manno Y, Takaoka K, Sakurai K.
    J Oral Pathol Med; 2004 Nov 20; 33(10):614-21. PubMed ID: 15482328
    [Abstract] [Full Text] [Related]

  • 32. Cyclooxygenase 2: from inflammation to carcinogenesis.
    Ristimäki A.
    Novartis Found Symp; 2004 Nov 20; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
    [Abstract] [Full Text] [Related]

  • 33. Is cyclooxygenase-2 important in skin carcinogenesis?
    Fischer SM.
    J Environ Pathol Toxicol Oncol; 2002 Nov 20; 21(2):183-91. PubMed ID: 12086405
    [Abstract] [Full Text] [Related]

  • 34. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM, Lindley C.
    Ann Pharmacother; 2003 Nov 20; 37(11):1664-74. PubMed ID: 14565811
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives.
    Dermond O, Rüegg C.
    Drug Resist Updat; 2001 Oct 20; 4(5):314-21. PubMed ID: 11991685
    [Abstract] [Full Text] [Related]

  • 36. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB, Hulscher JB, Steller EP, van Lanschot JJ, Richel DJ.
    Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2207-12. PubMed ID: 14640057
    [Abstract] [Full Text] [Related]

  • 37. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
    Ferrandina G, Ranelletti FO, Legge F, Lauriola L, Salutari V, Gessi M, Testa AC, Werner U, Navarra P, Tringali G, Battaglia A, Scambia G.
    Clin Cancer Res; 2003 Oct 01; 9(12):4324-31. PubMed ID: 14555502
    [Abstract] [Full Text] [Related]

  • 38. The role of cyclooxygenases in inflammation, cancer, and development.
    Williams CS, Mann M, DuBois RN.
    Oncogene; 1999 Dec 20; 18(55):7908-16. PubMed ID: 10630643
    [Abstract] [Full Text] [Related]

  • 39. Role of COX-2 selective inhibitors for prevention and treatment of cancer.
    Amir M, Agarwal HK.
    Pharmazie; 2005 Aug 20; 60(8):563-70. PubMed ID: 16124396
    [Abstract] [Full Text] [Related]

  • 40. Neuronal expression of cyclooxygenase-2, a pro-inflammatory protein, in the hippocampus of patients with schizophrenia.
    Yokota O, Terada S, Ishihara T, Nakashima H, Kugo A, Ujike H, Tsuchiya K, Ikeda K, Saito Y, Murayama S, Ishizu H, Kuroda S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul 20; 28(4):715-21. PubMed ID: 15276698
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.